Covid-19 roundup: Pfizer, BioNTech start US human trial; World leaders (not including the US) pledge $8 billion in vaccine, treatment research
Last week, partners Pfizer and BioNTech joined the elite group of CanSino, Moderna and Oxford who have begun human trials of their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
